Mumbai, a hub for pharmaceutical manufacturing in India , boasts several key firms specializing in the synthesis of Cyproheptadine Hydrochloride API (CAS No 74050-97-8). Key players offer superior forms of this vital drug's core ingredient, catering to Indian and global markets. Identifying relia